PurposeThe primary purpose of this study was to demonstrate intraobserver/interobserver reproducibility for novel semiautomated measurements of hepatic volume used for Yttrium-90 dose calculations as well as whole-liver and necrotic-liver (hypodense/nonenhancing) tumor volume after radioembolization. The secondary aim was to provide initial comparisons of tumor volumetric measurements with linear measurements, as defined by Response Evaluation Criteria in Solid Tumors criteria, and survival outcomes.MethodsBetween 2006 and 2009, 23 consecutive radioembolization procedures were performed for 14 cases of hepatocellular carcinoma and 9 cases of hepatic metastases. Baseline and follow-up computed tomography obtained 1 month after treatment were...
Radioembolization is a valuable therapeutic option in patients with unresectable intrahepatic cholan...
Radioembolization is increasingly used as a bridge to resection (i.e., radiation lobectomy). It comb...
Objective: To investigate clinical and laboratory toxicity in patients with unresectable liver metas...
Purpose: To retrospectively compare early response to yttrium-90 radioembolization (Y90) according t...
In transarterial radioembolization (TARE) of hepatocellular carcinoma (HCC) with Yttrium-90 (Y-90) m...
Radioembolization (RE) with glass microspheres (MS) loaded with Yttrium-90 (90Y) has been used to tr...
Purpose: To Evaluate the correlation between tumor dosimetric parameters with objective tumor respon...
International audienceThe aim of this study was to quantitatively evaluate the body surface area (BS...
Radioembolization is increasingly used as a bridge to resection (i.e., radiation lobectomy). It comb...
Yttrium-90 (90Y) microsphere therapy is being utilized as a treatment option for patients with prima...
Dosimetry in liver radioembolization with 90Y microspheres is a fundamental tool, both for the optim...
Purpose: To retrospective compare early response to Yttrium 90 radioembolization (Y90) in terms of v...
BACKGROUND: Selective internal radiation therapy (SIRT) is a promising treatment for unresectable he...
Selective internal radiotherapy (SIRT) using Yttrium-90 labeled resin microspheres is increasingly u...
90Y-microsphere therapy has been widely accepted as a treatment option for both primary and metastat...
Radioembolization is a valuable therapeutic option in patients with unresectable intrahepatic cholan...
Radioembolization is increasingly used as a bridge to resection (i.e., radiation lobectomy). It comb...
Objective: To investigate clinical and laboratory toxicity in patients with unresectable liver metas...
Purpose: To retrospectively compare early response to yttrium-90 radioembolization (Y90) according t...
In transarterial radioembolization (TARE) of hepatocellular carcinoma (HCC) with Yttrium-90 (Y-90) m...
Radioembolization (RE) with glass microspheres (MS) loaded with Yttrium-90 (90Y) has been used to tr...
Purpose: To Evaluate the correlation between tumor dosimetric parameters with objective tumor respon...
International audienceThe aim of this study was to quantitatively evaluate the body surface area (BS...
Radioembolization is increasingly used as a bridge to resection (i.e., radiation lobectomy). It comb...
Yttrium-90 (90Y) microsphere therapy is being utilized as a treatment option for patients with prima...
Dosimetry in liver radioembolization with 90Y microspheres is a fundamental tool, both for the optim...
Purpose: To retrospective compare early response to Yttrium 90 radioembolization (Y90) in terms of v...
BACKGROUND: Selective internal radiation therapy (SIRT) is a promising treatment for unresectable he...
Selective internal radiotherapy (SIRT) using Yttrium-90 labeled resin microspheres is increasingly u...
90Y-microsphere therapy has been widely accepted as a treatment option for both primary and metastat...
Radioembolization is a valuable therapeutic option in patients with unresectable intrahepatic cholan...
Radioembolization is increasingly used as a bridge to resection (i.e., radiation lobectomy). It comb...
Objective: To investigate clinical and laboratory toxicity in patients with unresectable liver metas...